Insider · CIK 0001341526

Day Wesley

Reports to the SEC for 1 company · MOUNTAIN VIEW, CA

sec.gov

Transactions

Companies

Filings

CIK

0001341526

Forms 4 and 5

Insider transactions

43 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-07-01	VIVUS INCS Sale	VP, Clinical Development	SSale	−7,881 sh	$2.32	−$18.3K	49,118
2015-01-29	VIVUS INCS Sale	VP, Clinical Development	SSale	−472 sh	$2.78	−$1,312.16	56,999
2015-01-23	VIVUS INCEmployee Stock Option (right to buy)A Award	VP, Clinical Development	AAward	+233K sh	—	—	232,900
2015-01-23	VIVUS INCA Award	VP, Clinical Development	AAward	+24.5K sh	—	—	57,471
2015-01-01	VIVUS INCS Sale	VP, Clinical Development	SSale	−2,549 sh	$3.04	−$7,748.96	46,569
2014-07-02	VIVUS INCD Disposition to Issuer	VP, Clinical Development	DDisposition to Issuer	−2,281 sh	$5.31	−$12.1K	32,971
2014-01-28	VIVUS INCEmployee Stock Option (right to buy)A Award	VP, Clinical Development	AAward	+38.3K sh	—	—	38,300
2014-01-28	VIVUS INCA Award	VP, Clinical Development	AAward	+4,200 sh	—	—	35,252
2014-01-22	VIVUS INCA Award	VP, Clinical Development	AAward	+30K sh	—	—	31,052
2013-01-25	VIVUS INCIncentive Stock Option (right to buy)A Award	VP, Clinical Development	AAward	+8,100 sh	—	—	8,100
2013-01-25	VIVUS INCNon-Qualified Stock Option (right to buy)A Award	VP, Clinical Development	AAward	+41.9K sh	—	—	41,900
2012-07-18	VIVUS INCS Sale	VP, Clinical Development	SSale	−16.8K sh	$30.36	−$510K	0
2012-02-23	VIVUS INCS Sale	VP, Clinical Development	SSale	−9,958 sh	$20.69	−$206K	16,800
2012-02-23	VIVUS INCM Exercise/Conversion	VP, Clinical Development	MExercise/Conversion	+9,958 sh	$3.28	+$32.7K	26,758
2012-02-23	VIVUS INCM Exercise/Conversion	VP, Clinical Development	MExercise/Conversion	+19.7K sh	$4.25	+$83.9K	36,538
2012-02-23	VIVUS INCS Sale	VP, Clinical Development	SSale	−19.7K sh	$20.69	−$408K	16,800
2012-02-23	VIVUS INCM Exercise/Conversion	VP, Clinical Development	MExercise/Conversion	+50.3K sh	$4.25	+$214K	67,062
2012-02-23	VIVUS INCS Sale	VP, Clinical Development	SSale	−50.3K sh	$20.69	−$1.04M	16,800
2012-02-23	VIVUS INCEmployee Stock Option (right to buy)M Exercise/Conversion	VP, Clinical Development	MExercise/Conversion	−19.7K sh	—	—	0
2012-02-23	VIVUS INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion	VP, Clinical Development	MExercise/Conversion	−9,958 sh	—	—	0
2012-02-23	VIVUS INCNon-Qualified Stock Option (right to buy)M Exercise/Conversion	VP, Clinical Development	MExercise/Conversion	−50.3K sh	—	—	0
2012-01-27	VIVUS INCIncentive Stock Option (right to buy)A Award	VP, Clinical Development	AAward	+8,591 sh	—	—	8,591
2012-01-27	VIVUS INCNon-Qualified Stock Option (right to buy)A Award	VP, Clinical Development	AAward	+41.4K sh	—	—	41,409
2012-01-09	VIVUS INCM Exercise/Conversion	VP, Clinical Development	MExercise/Conversion	+30K sh	$3.28	+$98.4K	46,800
2012-01-09	VIVUS INCS Sale	VP, Clinical Development	SSale	−30K sh	$11.50	−$345K	16,800
2012-01-09	VIVUS INCEmployee Stock Option (right to buy)M Exercise/Conversion	VP, Clinical Development	MExercise/Conversion	−30K sh	—	—	0
2011-11-11	VIVUS INCEmployee Stock Option (right to buy)M Exercise/Conversion	VP, Clinical Development	MExercise/Conversion	−20K sh	—	—	0
2011-11-11	VIVUS INCEmployee Stock Option (right to buy)M Exercise/Conversion	VP, Clinical Development	MExercise/Conversion	−3,400 sh	—	—	0
2011-11-11	VIVUS INCM Exercise/Conversion	VP, Clinical Development	MExercise/Conversion	+3,400 sh	$3.13	+$10.6K	20,200
2011-11-11	VIVUS INCM Exercise/Conversion	VP, Clinical Development	MExercise/Conversion	+20K sh	$3.28	+$65.7K	40,242
2011-11-11	VIVUS INCS Sale	VP, Clinical Development	SSale	−23.4K sh	$9.87	−$231K	16,800
2011-01-21	VIVUS INCEmployee Stock Option (right to buy)A Award	VP, Clinical Development	AAward	+50K sh	—	—	50,000
2010-12-17	VIVUS INCEmployee Stock Option (right to buy)M Exercise/Conversion	VP, Clinical Development	MExercise/Conversion	−60K sh	—	—	0
2010-12-17	VIVUS INCS Sale	VP, Clinical Development	SSale	−70.6K sh	$9.54	−$673K	16,800
2010-12-17	VIVUS INCM Exercise/Conversion	VP, Clinical Development	MExercise/Conversion	+60K sh	$3.26	+$196K	87,400
2010-12-17	VIVUS INCS Sale	VP, Clinical Development	SSale	−66.6K sh	$9.54	−$635K	20,800
2010-01-22	VIVUS INCEmployee Stock Option (right to buy)A Award	VP, Clinical Development	AAward	+40K sh	—	—	40,000
2009-01-23	VIVUS INCNon-Qualified Stock Option (right to buy)A Award	VP, Clinical Development	AAward	+77.3K sh	—	—	77,256
2009-01-23	VIVUS INCIncentive Stock Option (right to buy)A Award	VP, Clinical Development	AAward	+22.7K sh	—	—	22,744
2008-05-14	VIVUS INCP Purchase	VP, Clinical Development	PPurchase	+3,297 sh	$4.17	+$13.8K	16,843
2007-01-29	VIVUS INCIncentive Stock Option (right to buy)A Award	VP, Clinical Development	AAward	+19.7K sh	—	—	19,738
2007-01-29	VIVUS INCNon-Qualified Stock Option (right to buy)A Award	VP, Clinical Development	AAward	+50.3K sh	—	—	50,262
2006-01-30	VIVUS INCIncentive Stock Option (right to buy)A Award	VP, Clinical Development	AAward	+3,400 sh	—	—	3,400

Recent filings

Accepted (ET)
Apr 204/A
VIVUS INC0001123292-16-002113
SEC(opens sec.gov)
Jul 64
VIVUS INC0001123292-15-001000
SEC(opens sec.gov)
Jan 304
VIVUS INC0001104659-15-005694
SEC(opens sec.gov)
Jan 274
VIVUS INC0001104659-15-004782
SEC(opens sec.gov)
Jul 74
VIVUS INC0001104659-14-050311
SEC(opens sec.gov)
Jan 304
VIVUS INC0001104659-14-005314
SEC(opens sec.gov)
Jan 244
VIVUS INC0001104659-14-004123
SEC(opens sec.gov)
Jan 294
Day Wesley0001104659-13-005736
SEC(opens sec.gov)
Jul 204
Day Wesley0001104659-12-050215
SEC(opens sec.gov)
Feb 244
Day Wesley0001104659-12-012638
SEC(opens sec.gov)

Companies

VIVUS INCVP, Clinical Development

Address

1172 CASTRO STREET

MOUNTAIN VIEW, CA, 94040